American Elements Logo and U.S. Registered Trademark
Tris(cyclopentadienyl)gadolinium
Gd(C5H5)3 1272-21-5
Product
Product Code
Order or Specifications
99% Tris(cyclopentadienyl)gadolinium
GD-TC-02
 Contact American Elements
99.5% Tris(cyclopentadienyl)gadolinium
GD-TC-025
 Contact American Elements
99.9% Tris(cyclopentadienyl)gadolinium
GD-TC-03
 Contact American Elements
99.95% Tris(cyclopentadienyl)gadolinium
GD-TC-035
 Contact American Elements
99.99% Tris(cyclopentadienyl)gadolinium
GD-TC-04
 Contact American Elements
99.999% Tris(cyclopentadienyl)gadolinium
GD-TC-05
 Contact American Elements
Tris(cyclopentadienyl)gadolinium is one of numerous organo-metallic compounds sold by American Elements under the tradename AE Organo-Metallics™ for uses requiring non-aqueous solubility such as recent solar energy and water treatment applications. Similar results can sometimes also be achieved with Nanoparticles (also see Nanotechnology and Quantum Dots) and by thin film deposition. Note American Elements additionally supplies many materials as solutions. Tris(cyclopentadienyl)gadolinium is generally immediately available in most volumes. High purity, submicron and nanopowder forms may be considered. Additional technical, research and safety information is available.

Gadolinium is a Block F, Group 3, Period 6 element. The electronic configuration is [Xe]4f75d16s2. In its elemental form gadolinium's CAS number is 7440-54-2. The gadolinium atom has a radius of 178.7.pm and it's Van der Waals radius is unknown. Gadolinium is utilized for both its high magnetic moment (7.94µB) and in phosphors and scintillator material. When complexed with EDTA ligands, it is used as an injectable contrast agent for patients undergoing magnetic resonance imaging. Gadolinium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder.

Formula CAS No. Appearance Molecular Weight
Gd(C5H5)3 1272-21-5 352.53
PRODUCT CATALOG Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc.
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements.

 

Recent Research & Development for Gadolinium

  • Gadolinium chloride suppresses styrene-induced cytochrome P450s expression in rat liver. Biomed Res. 2008 Dec;28(6):323-30.

  • Gadolinium and nephrogenic systemic fibrosis: association or causation. Nephrology (Carlton). 2008 Jun;13(3):235-41. Epub 2008 Jan 23.

  • Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Int J Cancer. 2008 May 1;122(9):1981-6.

  • Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature. Skeletal Radiol. 2008 May;37(5):457-64. Epub 2008 Mar 7.

  • Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol. 2008 Apr;190(4):1060-8.

  • MRI of mandibular osteonecrosis secondary to bisphosphonates. AJR Am J Roentgenol. 2008 Apr;190(4):949-55.

  • Rapid and quantitative DNA analysis of genetic mutations for polycystic kidney disease (PKD) using magnetic/luminescent nanoparticles. Anal Bioanal Chem. 2008 Apr;390(7):1829-35. Epub 2008 Feb 7.

  • Differential regulation of neutrophil CD18 integrin function by di- and tri-valent cations: manganese vs. gadolinium. Ann Biomed Eng. 2008 Apr;36(4):647-60. Epub 2008 Mar 4.

  • Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis. 2008 Apr;67(4):511-7. Epub 2007 Jul 20.

  • Molecular imaging of {alpha}v{beta}3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovasc Res. 2008 Apr 1;78(1):148-57. Epub 2008 Jan 3.

  • Preconditioning with death ligands FasL and TNF-alpha protects the cirrhotic mouse liver against ischaemic injury. Gut. 2008 Apr;57(4):492-9. Epub 2007 Dec 13.

  • Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel Imaging: Comparison with a Standard T2-Weighted Sequence for Detection of Focal Liver Lesions. Invest Radiol. 2008 Apr;43(4):261-266.

  • Left Ventricular Postmyocardial Infarction Remodeling Studied by Combining MR-Tagging With Delayed MR Contrast Enhancement. Invest Radiol. 2008 Apr;43(4):219-228.

  • Synthesis of a new gadolinium complex with a high affinity for human serum albumin and its manifold physicochemical characterization by proton relaxation rate analysis, NMR diffusometry and electrospray mass spectrometry. J Inorg Biochem. 2008 Apr;102(4):721-30. Epub 2007 Nov 17.

  • Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol. 2008 Apr;214(5):584-93.

  • Optimized 3D bright blood MRI of aortic plaque at 3 T. Magn Reson Imaging. 2008 Apr;26(3):330-6. Epub 2008 Feb 20.

  • Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure. Nephrol Dial Transplant. 2008 Apr;23(4):1467. No abstract available.

  • Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant. 2008 Apr;23(4):1233-40. Epub 2008 Feb 5.

  • Regulation of stretch-activated ANP secretion by chloride channels. Peptides. 2008 Apr;29(4):613-21. Epub 2007 Dec 8.

  • Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys. Radiology. 2008 Apr;247(1):88-97. Epub 2008 Feb 21.

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com